Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin’s disease

Author： Kömürcü Ş.   Özet A.   Altundag M.   Arpaci F.   Öztürk B.   Celasun B.   Tezcan Y.  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.81, Iss.1, 2002-01, pp. : 57-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

By Ianni Mauro Di   Ballanti Stelvio   Iodice Giuseppe   Reale Antonia   Falzetti Franca   Minelli Olivia   Serio Gabriella   Martelli Massimo F   Dammacco Franco   Vacca Angelo   Ria Roberto  

Hematology, Vol. 17, Iss. 1, 2012-01 ,pp. : 23-27

Maney Publishing

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

By Kim Min   Kim Shin   Lee Sung   Sym Sun   Lee Dae   Jang Seongsoo   Park Chan   Chi Hyun   Huh Jooryung   Suh Cheolwon  

Annals of Hematology, Vol. 86, Iss. 6, 2007-06 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation

By Gemmel C.   Cremer F.   Weis M.   Witzens M.   Moldenhauer G.   Koniczek K.-H.   Imbach U.   Ho A.   Moos M.   Goldschmidt H.  

Annals of Hematology, Vol. 81, Iss. 2, 2002-02 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite

Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin’s disease

By Claviez Alexander  

Annals of Hematology, Vol. 83, Iss. 4, 2004-04 ,pp. : 237-241

Springer Publishing Company

Access to resources Recommend Favorite

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

By Glossmann J.-P.   Josting A.   Pfistner B.   Paulus U.   Engert A.  

Annals of Hematology, Vol. 81, Iss. 8, 2002-08 ,pp. : 424-429

Springer Publishing Company

Access to resources Recommend Favorite